Resistin-binding peptide antagonizes role of resistin on white adipose tissue

Acta Pharmacologica Sinica

Volumn 28, Issue 2, 2007, Pages 221-226

  Gu, Nan ^a   Han, Shu Ping ^a   Fei, Li ^a   Pan, Xiao Qin ^a   Guo, Mei ^a   Chen, Rong Hua ^a   Guo, Xi Rong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Endocrine function; Lipid metabolism; Resistin; Resistin binding peptide; White adipose tissue

Indexed keywords

ADIPONECTIN; FATTY ACID; MESSENGER RNA; PROTEIN DERIVATIVE; RECOMBINANT PROTEIN; RESISTIN; RESISTIN BINDING PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; LIPID METABOLISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; CARRIER PROTEINS; FATTY ACIDS, NONESTERIFIED; LIPOLYSIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846497225     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00480.x     Document Type: Article

References (24)

1. Klyde BJ, Hirsch J. Increased cellular proliferation in adipose tissue of adult rats fed a high-fat diet. J Lipid Res 1979; 20: 705-15.
2. Jazet IM, Pijl H, Meinders AE. Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med 2003; 61:194-212.
3. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-56.
4. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-12.
5. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359: 46-7.
6. Wolf G. Insulin resistance and obesity: resistin, a hormone secreted by adipose tissue. Nutr Rev 2004; 62: 389-94.
7. Moon B, Kwan JJ, Duddy N, Sweeny G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab 2003; 285: E106-15.
8. Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, Lazar MA. Activation of SOCS-3 by Resistin. Mol Cell Biol 2005; 25: 1569-75.
9. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 2004; 114: 224-31.
10. Liu F, Guo X, Gong H, Fei L, Pan X, Guo M. A resistin binding peptide selected by phage display inhibits 3T3-L1 preadipocyte differentiation. Chin Med J 2006; 119: 496-503.
11. Canova N, Lincova D, Farghali H. Inconsistent role of nitric oxide on lipolysis in isolated rat adipocytes. Physiol Res 2005; 54: 387-93.
12. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
13. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001; 288: 27-31.
14. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-8.
15. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-31.
16. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Investing 2000; 106; 473-81.
17. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003; 111: 121-4.
18. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002; 32: S14-23.
19. Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo RA. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 4649-55.
20. Ronnett GV, Kim EK, Landree LE, Tu Y. Fatty acid metabolism as a target for obesity treatment. Physiol Behav 2005; 85: 25-35.
21. Sethi JK, Hotamisligil GS. The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 1999; 10:19-29.
22. Jain RG, Phelps KD, Pekala PH. Tumor necrosis factor-alpha initiated signal transduction in 3T3-L1 adipocytes. J Cell Physiol 1999; 179: 58-66.
23. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10 697-703.
24. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2001; 51: 2325-8.